Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseClinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseClinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseClinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ Not yet recruitingNot Applicable An open label balanced randomized two treatment two sequence two period crossover single dose oral bio equivalence study (celecoxib 100mg capsules)of PraNa Bioscience Inc USA and CELEBREX(celecoxib)100 mg capsules of G D Searle LLC division of pfizer inc NY NY 10017 in normal healthy adult human subjects under fed conditions
100 Clinical Results associated with Prana Bioscience, Inc.
0 Patents (Medical) associated with Prana Bioscience, Inc.
100 Deals associated with Prana Bioscience, Inc.
100 Translational Medicine associated with Prana Bioscience, Inc.